Angina Lecture 1 and 2 Flashcards
Cardiac muscle is highly
efficient extracting O2 even at rest (increased O2 delivery to myocardial tissue is dependent on CORONARY ARTERY vasodilation): think shear stress to dilate vessels or nitrates
What contributes to myocardial supply and demand?
Supply: vascular resistance and coronary blood flow (O2 carrying capacity);
Demand: (HR, contractility, systolic wall tension)
Angina usually occurs in patients with
CAD involving at least one epicardial artery; also valvular heart disease (increase strength of contractility and increase O2 demand in myocardium), hypertrophic cardiomyopathy, uncontrolled HTN (heart overtaxed even at rest)
As myocardial O2 delivery falls:
- anaerobic glycolysis inadequate to maintain cellular functions
- ATP and creatine phosphate levels fall
- IC and EC acidosis develops
- EC levels of K, lactate, phosphate, and FA levels rise;
elevated EC ____ is the most important contributor to
K; electrophysiologic changes of ischemia (increased K leaks outward)
Gradients exist between _____ in ischemia:
ischemic and normal cells, and seen on EKG;
in phase 4, IC positive current goes from less neg to ischemic cells to more negative normal cells (diastolic current); FOCUS MORE ON systolic current of injury with AP of ischemic cells being more negative than normal cells during phase 2 and 3 with IC positive current going from NORMAL to ISCHEMIC cells
How to diagnose ischemia?
Noninvasive:
- stress testing (treadmill with 6-12 min of exercise if they can; try to hit 85% max HR, or 220-age)
- can do test with ECG alone if normal baseline ECG (positive with at least 1 mm of horizontal or downsloping ST depression)
- if baseline ECG is ABNORMAL, do imaging like echo to look at wall motion abnormalities or perfusion imaging
- If patient CAN’T EXERCISE, use pharmacologic stress with dobutamine (sympathomimetic drug with beta-1 receptors to increase HR and contractility; or adenosine or dipyridamole as vasodilators, but stenotic arteries can’t respond to vasodilation stimulus and leads to coronary steal)
Diagnosis of CAD:
- Stress testing reveals ONLY presence of hemodynamic significant lesions, but WON’T directly image the vessels
- For direct imaging of coronaries, think coronary angiogram (minority: CT angiogram)
- Maybe consider electron beam CT scanning: ID Ca in the coronaries, and very useful in predicting absence of CAD
Medical management of CAD:
- ID and treat risk factors for cardiovascular disease (lipid abnormalities for cholesterol, smoking, diabetes, HTN);
Aim is to FIRST prevent MI and death to increase QUANTITY of life; however, want to reduce symptoms of angina and occurrence of ischemia or QUALITY of life;
use strategy that has greater chance of PREVENTING DEATH
Aspirin (Unit IV)
Class: NSAID
Mech: Irreversible inhibition of platelet COX (need COX for prostaglandin and thromboxane synthesis; no Thr A2, no platelet aggregation)
Thera: Reduction in adverse events (MI, CVA, death); for those w/stable angina, unstable angina, acute MI, prophylaxis
Important SE’s: bleeding complications with GI bleeds, bruises, anemia with increased aspirin dose
Misc: Low-doses; if you’re allergic, you’ll get asthma
Ticlopidine (Ticlid)
Class: Thienopyridine derivitive
Mech: Inhibits platelet aggregation by ADP; reduces blood viscosity by decreasing plasma fibrinogen and increasing RBC deformability
Thera: Aspirin alternative
Important SE’s: Neutropenia and, rarely, TTP
Misc: Not really used anymore (no decrease in adverse events in those w/ stable angina)
Clopidogrel (Plavix)
Class: Thienopyridine derivitive
Mech: Selectively and irreversibly inhibits ADP binding to P2Y12 (blocks ADP-dependent activation of glycoprotein IIb/IIIa complex)
Thera: Great antithrombotic (compared to aspirin or ticlopidine)
Important SE’s: Bleeding (more so than e.g. aspirin)
Misc: No surgical or dental procedures if patient taking this
Prasugrel (Effient)
Class: Thienopyridine derivitive
Mech: Irreversibly binds P2Y12 receptor (G protein-coupled chemoreceptor for ADP)
Thera: Reduce thrombotic events in those w/percutaneous coronary intervention (e.g., stent), like ACS
Important SE’s: Massive bleeding risk
Misc: more potent antiplatelet agent compared to e.g. aspirin and clopidogrel in reducing rates of death, CVA, MI; limit this to
1. Patients less than 75
2. Weight more than 60 kg
3. No history of stroke or TIA
Ticagrelor (Brilinta)
Class: similar in structure to adenosine
Mech: blocks ADP receptors, but is a reversible blockade (different binding site than ADP)
Thera: ACS?; better mortality results compared to clopidogrel
Important SE’s: non-lethal bleeding
Misc: no hepatic activation and so faster onset of action; eliminated faster so more dosing required and issues with patient compliance
Dipyradimole (Persantine)
Class: Pyrimido-pyrimidine derivitive
Mech: Increases platelet intracellular cAMP (inhibits phosphodiesterase 5, activates adenylate cyclase, inhibits uptake of adenosine from vascular endothelium and RBCs)
Thera: Decrease peripheral vascular disease (as an adjunct); stress test of heart
Important SE’s: Vasodilation of coronary arteries can enhance exercise-induced ischemia (because it elevates extracellular adenosine levels)